BioVaxys Technology Corp. (BVAXF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 10:01AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 8.50M |
| Enterprise Value | 8.50M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 8.86 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.67 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.12 |
| 52-Week Change 3 | 132.34% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 0.0758 |
| 52 Week Low 3 | 0.0091 |
| 50-Day Moving Average 3 | 0.0593 |
| 200-Day Moving Average 3 | 0.0310 |
Share Statistics
| Avg Vol (3 month) 3 | 154k |
| Avg Vol (10 day) 3 | 58.37k |
| Shares Outstanding 5 | 145.11M |
| Implied Shares Outstanding 6 | 156.46M |
| Float 8 | 125.3M |
| % Held by Insiders 1 | 6.61% |
| % Held by Institutions 1 | 0.00% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Apr 28, 2020 |
Financial Highlights
Currency in CAD.Fiscal Year
| Fiscal Year Ends | Oct 31, 2022 |
| Most Recent Quarter (mrq) | Jul 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -32.90% |
| Return on Equity (ttm) | -451.08% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -12.57M |
| Diluted EPS (ttm) | -0.0900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 423 |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.46 |
| Book Value Per Share (mrq) | -0.00 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1.26M |
| Levered Free Cash Flow (ttm) | -1.5M |
© 2024 Yahoo. All rights reserved.